Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > Cash from Financing Activities

Ampio Pharmaceuticals Cash from Financing Activities Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly Cash from Financing Activities from 2009 to 2018.
  • Ampio Pharmaceuticals Cash from Financing Activities for the quarter ending September 09, 2018 was $7m a -24.06% decrease of -2m year over year
  • Ampio Pharmaceuticals Cash from Financing Activities for the last 12 months ending September 09, 2018 was $20m a 25.18% increase of 5m year over year
  • Ampio Pharmaceuticals Annual Cash from Financing Activities for 2017 was $15m a 76.15% increase of 11m from 2016
  • Ampio Pharmaceuticals Annual Cash from Financing Activities for 2016 was $4m a -499.67% decrease of -18m from 2015
  • Ampio Pharmaceuticals Annual Cash from Financing Activities for 2015 was $21m a -225.79% decrease of -48m from 2014
Other Cash Flow Metrics:
  • Ampio Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-3m a 19.89% decrease of -1m year over year
  • Ampio Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-3m a 68.32% decrease of -2m year over year
  • Ampio Pharmaceuticals Total Revenue for the quarter ending December 12, 2015 was $0m a 95.43% increase of 0m year over year
View Chart On Koyfin

Quarterly AMPE Cash from Financing Activities Data

09/2018$7m
06/2018$0m
03/2018$3m
12/2017$9m
09/2017$0m
06/2017$6m
12/2016$0m
09/2016$3m
12/2015$16m
09/2015$5m

Annual AMPE Cash from Financing Activities Data

2017$15m
2016$4m
2015$21m
2014$69m
2013$29m
2012$16m
2011$20m
2010$3m
2009$1m